PRF Technologies Ltd. (PRFX): EPS (Diluted)
-$7.47
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$7.47 | n/m | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | -$105.52 | n/m | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | -$122.94 | n/c | 2026-03-26, From 2023-01-01 |
| 2022-12-31 | -$63.46 | n/c | 2025-04-07, From 2022-01-01 |
| 2021-12-31 | -$7.25 | n/c | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | -$1.25 | n/a | 2023-03-15, From 2020-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | -$7.47 | n/m |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | -$0.15 | n/m |
| Skinvisible, Inc. (SKVI) | 2024-12-31 | -$0.11 | n/m |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | -$0.25 | n/m |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | -$0.38 | n/m |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | -$16.06 | n/m |
| Genelux Corp (GNLX) | 2025-12-31 | -$0.86 | n/m |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | -$3.20 | n/m |
| Altimmune, Inc. (ALT) | 2025-12-31 | -$1.00 | n/m |
Compare PRFX, BDPT, SKVI, JUNS side by side · Screen every company in Pharmaceutical Preparations ↗